Skip to main content

Table 5 Predictors of death in cases of V. vulnificus in the United States during 1990 to 2010

From: Antibiotic use for Vibrio infections: important insights from surveillance data

 

Fatal N (%)

Non-fatal N (%)

Crude OR (95% CI)

Adjusted OR (95% CI)

Age, mean (SD)

56.6 (13.5)

58.0 (17.8)

0.995 (0.989-1.001)

0.99 (0.98-0.998)

Gender

    

  Female

72 (15.2)

135 (12.6)

reference

reference

  Male

402 (84.8)

939 (87.4)

0.80 (0.59-1.09)

0.70 (0.49-1.000)

Year of notification

    

  1990 – 1996

103 (21.7)

194 (18.1)

reference

reference

  1997 – 2010

371 (78.3)

880 (81.9)

0.79 (0.61-1.04)

0.99 (0.73-1.34)

Pre-existing conditions

    

  0

41 (8.6)

397 (37.0)

reference

reference

  1

107 (22.6)

277 (25.8)

3.74 (2.53-5.53)

4.52 (2.92-6.99)

  2

194 (40.9)

227 (21.1)

8.28 (5.69-12.03)

10.30 (6.72-15.78)

  3 or more

132 (27.8)

173 (16.1)

7.39 (4.99-10.95)

9.31 (5.93-14.62)

Clinical presentation

    

  Wound

68 (14.3)

406 (37.8)

reference

reference

  Gastroenteritis

20 (4.2)

49 (4.6)

2.44 (1.36-4.35)

1.52 (0.77-3.01)

  Septicaemia

333 (70.3)

493 (45.9)

4.03 (3.01-5.40)

2.64 (1.92-3.63)

  Other

53 (11.2)

126 (11.7)

2.51 (1.67-3.79)

1.69 (1.04-2.74)

Antibiotic treatment

    

  Quinolone only

13 (2.7)

68 (6.3)

reference

reference

  Quinolone and other/s

106 (22.4)

335 (31.2)

1.66 (0.88-3.12)

1.44 (0.73-2.84)

  Antibiotic/s, not quinolone

208 (43.9)

534 (49.7)

2.04 (1.10-3.77)

1.84 (0.95-3.56)

  None

147 (31.0)

137 (12.8)

5.61 (2.97-10.62)

7.89 (3.94-15.80)